IIT Delhi study reveals mechanisms driving SARS-CoV-2 evolution in humans

0
42
IIT Delhi study reveals mechanisms driving SARS-CoV-2 evolution in humans

IIT Delhi researchers have published a study revealing the evolution of SARS-CoV-2 in humans, helping get a better insight into Covid-19 immunity

Topics


Coronavirus Tests | Coronavirus Vaccine

PTI 

Last Updated at May 29, 2022 17:43 IST

Researchers at the Indian Institute of Technology (IIT), Delhi have revealed the mechanisms driving the evolution of SARS-CoV-2 in humans which can help in better understanding of COVID-19’s pathogenesis, immune evasion and emergence of variants of concern.

According to the seven-member research team, CpG (a cytosine followed by a guanine) numbers in virus genomes have been linked to host-switching, the efficiency of virus replication, immune evasion and the ability of a virus to cause disease.

The researchers found that the rate of CpG depletion from SARS-CoV-2 genomes rapidly decreases after the first few months of evolution in humans. The research has been published in a journal, Molecular Biology and Evolution, and is titled “The Slowing Rate of CpG Depletion in SARS-CoV-2 Genomes is Consistent with Adaptations to the Human Host”.

“Zinc-finger antiviral protein (ZAP) is a host protein that can bind to CpG-rich regions in SARS-CoV-2, the causative agent of the COVID-19 pandemic, and recruits other host proteins to degrade the viral RNA. Several viruses including HIV-1, Influenza A virus and SARS-CoV-2 prefer to reduce their CpG content (by losing CpGs) to minimise the host immune response, thus allowing better virus replication and survival,” Vivekanandan Perumal from the Kusuma School of Biological Sciences, IIT Delhi told PTI.

“The team analysed over 1.4 million full-length SARS-CoV-2 sequences from across the world. They found that the rate of CpG depletion from SARS-CoV-2 genomes rapidly decreases after the first few months of evolution in humans.

“Furthermore, most SARS-CoV-2 variants of concern had lower CpG content. This work highlights the existence of selection pressures apart from ZAP that may lead to CpG depletion in SARS-CoV-2 genomes,” he added.

SARS-CoV-2 has a uracil-rich (uracil is one of the four building blocks of RNA) genome. The researchers have identified how uracils adjacent to CpGs contribute to the accelerated loss of CpGs from SARS-CoV-2 genomes.

“Our results lay the necessary groundwork for future studies on understanding the intricacies of virus-host interactions leading to CpG depletion,” IIT Delhi professor Manoj Menon said.

“We observed that the extent of CpG depletion in SARS-CoV-2 genomes is modest during the first 17 months of the pandemic corresponding to over 170 million documented human infections,” he said.

Dear Reader,



Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.


We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read More

LEAVE A REPLY

Please enter your comment!
Please enter your name here